Mikoderil Solution for external use, 1%, 20 ml

Mikoderil solution for plank beds.

approx.

1% 20ml (bottle-cap.) No. 1

Name ENG

MYCODERIL

Clinical and pharmacological group

Antifungal drug for external use

ATX code

Naftifine

Dosage

1% x 20ml

Structure

1 ml of solution contains: Active ingredient: naftifine hydrochloride 10 mg Excipients: propylene glycol - 50 mg

ethanol (ethyl alcohol 95%) - 400 mg

purified water - up to 1 ml

Indications

Fungal infections of smooth skin and skin folds (tinea corporis, tinea inquinalis)

interdigital mycoses (tinea manum, tinea pedum)

fungal infections of the nails (onychomycosis)

candidiasis of the skin

pityriasis versicolor

dermatomycosis (with or without itching).

Contraindications

Hypersensitivity to naftifine, benzyl alcohol or other components of the drug

pregnancy and lactation (the safety and efficacy of the drug in this category of patients has not been studied).

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

INN / Active ingredient

Naftifine hydrochloride

Specifications

Category

Antifungal

Scope of the medicinal product

Dermatology

Release form

Solution

Manufacturer country

Russia

Package quantity, pcs

one

Scope of application

Dermatology

Minimum age from

18 years

Way of introduction

Outwardly

Vacation conditions

Without recipe

Volume, ml.

20 ml

Brand name

OTCPharm

The amount of the dosage form in the primary package

20 ml

Primary packaging type

Dark glass dropper bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antifungal agent

Anatomical and therapeutic characteristics

D01AE22 Naftifine

Dosage form

Solution for external use

Packaging

Box

Expiration date in days

1095

Dosage (volume) of the substance in the preparation

naftifine hydrochloride - 10.0 mg

The target audience

Adult

Package weight, g

2

Mode of application

:

Outwardly.

In case of skin lesions, Mikoderil is applied once a day to the affected skin surface and adjacent areas, after thorough cleaning and drying (capturing approximately 1 cm of healthy skin along the edges of the affected area).

3 Duration of therapy for dermatomycosis - 2-4 weeks (if necessary - up to 8 weeks), with candidiasis - 4 weeks. < br> In case of nail damage, Mikoderil is applied 2 times a day to the affected nail.

Before the first use of the drug, the affected part of the nail is removed as much as possible with scissors or a nail file.

The duration of therapy for onychomycosis is up to 6 months.

To prevent relapse, treatment should be continued for at least 2 weeks after the disappearance of clinical symptoms.